Recent Finacing
Recent Raise
Avenge Bio is an oncology biotech developing cell-based immunotherapies using its LOCOcyte platform to deliver engineered cells producing local IL-2 and other immune effectors for peritoneal and solid tumors.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at AvengeBio.
